Tubidy
    Leadership Insights - Anilkumar Jain, CEO – API Business

    Leadership Insights - Anilkumar Jain, CEO – API Business

    01:18 |
    Download MP3

    Related Videos

    Sun Pharma Case Study | Story of Dilip Shanghvi - The Founder of Sun Pharma 3:46

    Sun Pharma Case Study | Story of Dilip Shanghvi - The Founder of Sun Pharma

    Sun Pharma Business Empire (100+ Countries) | How big is Sun Pharma ? 7:13

    Sun Pharma Business Empire (100+ Countries) | How big is Sun Pharma ?

    sun pharma share latest news today || sun pharma share price target tomorrow 1:29

    sun pharma share latest news today || sun pharma share price target tomorrow

    Business should have a higher purpose: Dilip Shangvi of Sun Pharma 3:11

    Business should have a higher purpose: Dilip Shangvi of Sun Pharma

    Sun Pharma Share News Today: Sun Pharma Share Latest News Today | Sun Pharma Share | 30th Sept 2024 1:18

    Sun Pharma Share News Today: Sun Pharma Share Latest News Today | Sun Pharma Share | 30th Sept 2024

    Sun Pharmaceutical Industries | Products and Brands | Owner 4:21

    Sun Pharmaceutical Industries | Products and Brands | Owner

    Why is Sun Pharma Worth $32 Billion? | Dilip Shanghvi Success Story | Business Case Study | Hindi 16:15

    Why is Sun Pharma Worth $32 Billion? | Dilip Shanghvi Success Story | Business Case Study | Hindi

    Sun Pharma Slips In Trade After Receiving A Warning Letter From The US FDA For Its Dadra Facility 1:54

    Sun Pharma Slips In Trade After Receiving A Warning Letter From The US FDA For Its Dadra Facility

    sun pharma share latest news today || sun pharma share price target tomorrow 1:29

    sun pharma share latest news today || sun pharma share price target tomorrow

    Sun Pharma Q1FY25: Net Profit, EBITDA, Margin Beat Est; US Formulation Sales At $466 m | CNBC TV18 1:25

    Sun Pharma Q1FY25: Net Profit, EBITDA, Margin Beat Est; US Formulation Sales At $466 m | CNBC TV18

    Sun Pharma Announces Outcome Of Phase-1 Obesity Trial Of GL0034 (Utreglutide) | CNBC TV18 0:54

    Sun Pharma Announces Outcome Of Phase-1 Obesity Trial Of GL0034 (Utreglutide) | CNBC TV18

    Citi Raises Targets On Torrent Pharma, DRL & Sun Pharma; Picks Cipla As Top Indian Pharma Bet 1:56

    Citi Raises Targets On Torrent Pharma, DRL & Sun Pharma; Picks Cipla As Top Indian Pharma Bet

    Dilip Shanghvi - Sun Pharma 18:51

    Dilip Shanghvi - Sun Pharma

    Stock Radar | Pharma stocks are back in action; Sun Pharma likely to hit fresh highs: Ruchit Jain 1:34

    Stock Radar | Pharma stocks are back in action; Sun Pharma likely to hit fresh highs: Ruchit Jain

    Sun Pharma offers to acquire remaining stake in Taro in an all-cash deal: Key details 2:26

    Sun Pharma offers to acquire remaining stake in Taro in an all-cash deal: Key details

    Sun Pharma Q4: What Are The Key Growth Drivers Aiding India & U.S Business? | CS Muralidharan 5:09

    Sun Pharma Q4: What Are The Key Growth Drivers Aiding India & U.S Business? | CS Muralidharan

    Sun Pharma 5:00

    Sun Pharma

    Expect Marginal Earnings Impact On Sun Pharma Due To Dadra Facility Warning Letter: InCred PMS 10:17

    Expect Marginal Earnings Impact On Sun Pharma Due To Dadra Facility Warning Letter: InCred PMS

    Sun Pharma CSR - Mobile Healthcare 1:42

    Sun Pharma CSR - Mobile Healthcare

    What's The Buzz On Cipla And Sun Pharma | ET Now 1:17

    What's The Buzz On Cipla And Sun Pharma | ET Now